167 related articles for article (PubMed ID: 27325482)
21. Patient-reported Quality of Life After SBRT, LDR, and HDR Brachytherapy for Prostate Cancer: A Comparison of Outcomes.
Paly JJ; Egleston BL; Wong JK; Burbure N; Sobczak ML; Hayes SB; Chen DYT; Horwitz EM; Hallman MA
Am J Clin Oncol; 2021 Apr; 44(4):131-136. PubMed ID: 33577175
[TBL] [Abstract][Full Text] [Related]
22. Stereotactic body radiotherapy for early stage non-small cell lung cancer in patients with subclinical interstitial lung disease.
Liu Y; Zhu Y; Wu R; Hu M; Zhang L; Lin Q; Weng D; Sun X; Liu Y; Xu Y
Transl Lung Cancer Res; 2020 Dec; 9(6):2328-2336. PubMed ID: 33489796
[TBL] [Abstract][Full Text] [Related]
23. Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.
Bezjak A; Paulus R; Gaspar LE; Timmerman RD; Straube WL; Ryan WF; Garces YI; Pu AT; Singh AK; Videtic GM; McGarry RC; Iyengar P; Pantarotto JR; Urbanic JJ; Sun AY; Daly ME; Grills IS; Sperduto P; Normolle DP; Bradley JD; Choy H
J Clin Oncol; 2019 May; 37(15):1316-1325. PubMed ID: 30943123
[TBL] [Abstract][Full Text] [Related]
24. Radiation-Induced Lung Injury: Assessment and Management.
Hanania AN; Mainwaring W; Ghebre YT; Hanania NA; Ludwig M
Chest; 2019 Jul; 156(1):150-162. PubMed ID: 30998908
[TBL] [Abstract][Full Text] [Related]
25. Correlation of dosimetric factors with the development of symptomatic radiation pneumonitis in stereotactic body radiotherapy.
Ryckman JM; Baine M; Carmicheal J; Osayande F; Sleightholm R; Samson K; Zheng D; Zhen W; Lin C; Zhang C
Radiat Oncol; 2020 Feb; 15(1):33. PubMed ID: 32054487
[TBL] [Abstract][Full Text] [Related]
26. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for symptomatic radiation pneumonitis after stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer.
Liu Y; Wang W; Shiue K; Yao H; Cerra-Franco A; Shapiro RH; Huang KC; Vile D; Langer M; Watson G; Bartlett G; Ai H; Sheski F; Jin JY; Zellars R; Fu P; Lautenschlaeger T; Kong FS
Radiother Oncol; 2021 Mar; 156():231-238. PubMed ID: 33096168
[TBL] [Abstract][Full Text] [Related]
28. Radiation-induced lung injury after breast cancer treatment: incidence in the CANTO-RT cohort and associated clinical and dosimetric risk factors.
Gueiderikh A; Sarrade T; Kirova Y; De La Lande B; De Vathaire F; Auzac G; Martin AL; Everhard S; Meillan N; Bourgier C; Benyoucef A; Lacornerie T; Pasquier D; Racadot S; Moignier A; Paris F; André F; Deutsch E; Duchemann B; Allodji RS; Rivera S
Front Oncol; 2023; 13():1199043. PubMed ID: 37456251
[TBL] [Abstract][Full Text] [Related]
29. Re-evaluating the risk factors for radiation pneumonitis in the era of immunotherapy.
Chen F; Niu J; Wang M; Zhu H; Guo Z
J Transl Med; 2023 Jun; 21(1):368. PubMed ID: 37287014
[TBL] [Abstract][Full Text] [Related]
30. Is individual perfusion dose-response different than ventilation dose-response for lung cancer patients treated with radiotherapy?
Forghani F; Castillo R; Castillo E; PhD BJ; Rusthoven C; Kwak J; Moiseenko V; Grills I; Miften M; Vinogradskiy Y; Guerrero T
Br J Radiol; 2023 Mar; 96(1143):20220119. PubMed ID: 36633096
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells in radiation-induced lung injury: From mechanisms to therapeutic potential.
Hou G; Li J; Liu W; Wei J; Xin Y; Jiang X
Front Cell Dev Biol; 2022; 10():1100305. PubMed ID: 36578783
[TBL] [Abstract][Full Text] [Related]
32. Pirfenidone for the prevention of radiation-induced lung injury in patients with locally advanced oesophageal squamous cell carcinoma: a protocol for a randomised controlled trial.
Chen C; Zeng B; Xue D; Cao R; Liao S; Yang Y; Li Z; Kang M; Chen C; Xu B
BMJ Open; 2022 Oct; 12(10):e060619. PubMed ID: 36302570
[TBL] [Abstract][Full Text] [Related]
33. Lung Subregion Partitioning by Incremental Dose Intervals Improves Omics-Based Prediction for Acute Radiation Pneumonitis in Non-Small-Cell Lung Cancer Patients.
Li B; Zheng X; Zhang J; Lam S; Guo W; Wang Y; Cui S; Teng X; Zhang Y; Ma Z; Zhou T; Lou Z; Meng L; Ge H; Cai J
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230812
[TBL] [Abstract][Full Text] [Related]
34. Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer.
Berg J; Halvorsen AR; Bengtson MB; Lindberg M; Halvorsen B; Aukrust P; Helland Å; Ueland T
Front Immunol; 2022; 13():875152. PubMed ID: 35911763
[TBL] [Abstract][Full Text] [Related]
35. Radiation-Induced Lung Injury-Current Perspectives and Management.
Rahi MS; Parekh J; Pednekar P; Parmar G; Abraham S; Nasir S; Subramaniyam R; Jeyashanmugaraja GP; Gunasekaran K
Clin Pract; 2021 Jul; 11(3):410-429. PubMed ID: 34287252
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.
Steuer CE; Behera M; Ernani V; Higgins KA; Saba NF; Shin DM; Pakkala S; Pillai RN; Owonikoko TK; Curran WJ; Belani CP; Khuri FR; Ramalingam SS
JAMA Oncol; 2017 Aug; 3(8):1120-1129. PubMed ID: 27978552
[TBL] [Abstract][Full Text] [Related]
37. A dynamic nomogram predicting symptomatic pneumonia in patients with lung cancer receiving thoracic radiation.
Zha Y; Zhang J; Yan X; Yang C; Wen L; Li M
BMC Pulm Med; 2024 Feb; 24(1):99. PubMed ID: 38409084
[TBL] [Abstract][Full Text] [Related]
38. Clinical and Dosimetric Risk Factors Associated With Radiation-Induced Lung Toxicities After Multiple Courses of Lung Stereotactic Body Radiation Therapy.
Li X; Yorke E; Jackson A; Yue Y; Simone CB; Apte AP; Rimner A; Gomez DR; Shaverdian N; Gelblum DY; Wu AJ; Shepherd AF
Adv Radiat Oncol; 2024 Jan; 9(1):101284. PubMed ID: 38260213
[TBL] [Abstract][Full Text] [Related]
39. Endobronchially Implanted Real-Time Electromagnetic Transponder Beacon-Guided, Respiratory-Gated SABR for Moving Lung Tumors: A Prospective Phase 1/2 Cohort Study.
Cheng JC; Buduhan G; Venkataraman S; Tan L; Sasaki D; Bashir B; Ahmed N; Kidane B; Sivananthan G; Koul R; Leylek A; Butler J; McCurdy B; Wong R; Kim JO
Adv Radiat Oncol; 2023; 8(5):101243. PubMed ID: 37408673
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Stage I Non-Small-Cell Lung Cancer Treatments for Patients Living With HIV: A Simulation Study.
Sigel K; Silverberg MJ; Crothers K; Park L; Lishchenko I; Han X; Leyden W; Kale M; Stone K; Sigel C; Wisnivesky J; Kong CY
Clin Lung Cancer; 2023 Nov; 24(7):e259-e267.e8. PubMed ID: 37407294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
